Models of practice agreements based on cooperation help pharmacists develop their pharmacies. D`Arkansan CPs apply to individual pharmacists, practitioners who are “authorized to prescribe drugs” and who are indicated in patients. The specific disease stipulates that pharmacists administer, with indicated medications that the pharmacist can use are necessary. Pharmacists are required to document their interventions for discussion with the collaborative practitioner and must keep these records for at least 2 years after the date of registration.  Advanced pharmacy services under a CPA are described as collaborative management of drug therapy (CDTM). [a] While traditional practice for pharmacists provides that the legal authority recognizes drug-related problems (DOP) and proposes solutions for PDs to prescription persons (e.g. B physicians), pharmacists who offer CDTMs solve PDs directly when they recognize them. This may include prescribing drugs to select and initiate drugs to treat a patient`s diagnosed illnesses (as described in the CPA), stopping the use of prescription or over-the-counter drugs, and modifying a patient`s drug treatment (for example. B change in strength, frequency, frequency of administration or duration of therapy), evaluation of a patient`s response to drug treatment (including drug treatment). , such as.B. a basic metabolic panel) and the continuation of drug therapy (with a new prescription).  According to the PPAC, the certified pharmacist-clinician is authorized to register for a personal DeK number (Drug Enforcement Administration). His field of activity is mainly general medicine and therapeutics.
Currently, they have a normative authority for these three types of disease status: high cholesterol, diabetes and hypertension in specific disease management protocols.  Pharmacists who wish to develop an agreement on a community practice may need help determining where to start. To support this process, a toolkit entitled “Advancing Team-Based Care through Collaborative Practice Agreements” has been developed. The toolkit is a resource for pharmacists that they can use in the development and implementation of collaborative practical agreements in a team-based spirit of care development. It offers a customizable model that can be used as a starting point for the development of an agreement on collaborative practices. The guidelines and legal requirements for the constitution of the CPA are defined on the basis of the state.  The federal government approved the CPAs in 1995.  Washington was the first state to pass laws allowing formal formation of CPAs. In 1979, Washington changed the practice of pharmaceutical requirements that provide for the formation of “collaborative drug therapy agreements.” [Citation required] Since February 2016, 48 states and Washington D.C have passed laws that allow the availability of CPAs.  The only two states that do not allow cpAs to be made available are Alabama and Delaware.
 Alabama pharmacists hoped that a CPA law, House Bill 494, would be passed in 2015.  The bill was introduced by Alabama House Of Representatives Representative Ron Johnson, but died in committee.  As part of the Cooperation Practices Agreement, a CPC has a provision for controlled and uncontrolled substances.  Pharmacists can help physicians treat chronic diseases of outpatients in different ways: CPAs are a priority in efforts to represent the interests of professional pharmaceutical organizations.